Structures of an active type III-A CRISPR effector complex

被引:6
|
作者
Smith, Eric M. [1 ,3 ]
Ferrell, Se [1 ]
Tokars, Valerie L. [2 ]
Mondragon, Alfonso [1 ]
机构
[1] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA
[3] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
基金
美国国家卫生研究院;
关键词
CAS IMMUNITY; CRYO-EM; EVOLUTIONARY CLASSIFICATION; CRYSTAL-STRUCTURE; RNA CLEAVAGE; CMR COMPLEX; DNA; PROTEIN; SYSTEM; REPEATS;
D O I
10.1016/j.str.2022.05.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Clustered regularly interspaced short palindromic repeats (CRISPR) and their CRISPR-associated proteins (Cas) provide many prokaryotes with an adaptive immune system against invading genetic material. Type III CRISPR systems are unique in that they can degrade both RNA and DNA. In response to invading nucleic acids, they produce cyclic oligoadenylates that act as secondary messengers, activating cellular nucleases that aid in the immune response. Here, we present seven single-particle cryo-EM structures of the type III-A Staphylococcus epidermidis CRISPR effector complex. The structures reveal the intact S. epidermidis effector complex in an apo, ATP-bound, cognate target RNA-bound, and non-cognate target RNA-bound states and illustrate how the effector complex binds and presents crRNA. The complexes bound to target RNA capture the type III-A effector complex in a post-RNA cleavage state. The ATP-bound structures give details about how ATP binds to Cas10 to facilitate cyclic oligoadenylate production.
引用
收藏
页码:1109 / +
页数:26
相关论文
共 50 条
  • [21] Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
    Tamulaitis, Gintautas
    Kazlauskiene, Migle
    Manakova, Elena
    Venclovas, Ceslovas
    Nwokeoji, Alison O.
    Dickman, Mark J.
    Horvath, Philippe
    Siksnys, Virginijus
    MOLECULAR CELL, 2014, 56 (04) : 506 - 517
  • [22] Crystal Structure of the Csm3-Csm4 Subcomplex in the Type III-A CRISPR-Cas Interference Complex
    Numata, Tomoyuki
    Inanaga, Hideko
    Sato, Chikara
    Osawa, Takuo
    JOURNAL OF MOLECULAR BIOLOGY, 2015, 427 (02) : 259 - 273
  • [23] Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector
    Gruschow, Sabine
    Adamson, Catherine S.
    White, Malcolm F.
    NUCLEIC ACIDS RESEARCH, 2021, 49 (22) : 13122 - 13134
  • [24] Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System
    Hatoum-Aslan, Asma
    Maniv, Inbal
    Samai, Poulami
    Marraffini, Luciano A.
    JOURNAL OF BACTERIOLOGY, 2014, 196 (02) : 310 - 317
  • [25] Lactococcus lactis type III-A CRISPR-Cas system cleaves bacteriophage RNA
    Millen, Anne M.
    Samson, Julie E.
    Tremblay, Denise M.
    Magadan, Alfonso H.
    Rousseau, Genevieve M.
    Moineau, Sylvain
    Romero, Dennis A.
    RNA BIOLOGY, 2019, 16 (04) : 461 - 468
  • [26] TYPE III-A HYPOPLASTIC THUMB
    MANSKE, PR
    MCCARROLL, FR
    JAMES, M
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1995, 20A (02): : 246 - 253
  • [27] Structure and engineering of the type III-E CRISPR-Cas7-11 effector complex
    Kato, Kazuki
    Zhou, Wenyuan
    Okazaki, Sae
    Isayama, Yukari
    Nishizawa, Tomohiro
    Gootenberg, Jonathan S.
    Abudayyeh, Omar O.
    Nishimasu, Hiroshi
    CELL, 2022, 185 (13) : 2324 - +
  • [28] Specialized Weaponry: How a Type III-A CRISPR-Cas System Excels at Combating Phages
    Niewoehner, Ole
    Jinek, Martin
    CELL HOST & MICROBE, 2017, 22 (03) : 258 - 259
  • [29] A type III-A CRISPR-Cas System employs degradosome necleases to ensure robust immunity
    Chou-Zheng, Lucy
    Hatoum-Aslan, Asma
    ELIFE, 2019, 8
  • [30] A type III-A CRISPR Cas system mediates co-transcriptional DNA cleavage at the transcriptiona bubbles in close proximity to active effectors
    Lin, Jinzhong
    Shen, Yulong
    Ni, Jinfeng
    She, Qunxin
    NUCLEIC ACIDS RESEARCH, 2021, 49 (13) : 7628 - 7643